Etoposide phosphate

Download report

Favorite

Events Timeline

Commercial

Clinical

Drug

Target

Variants

Financial

Trends

Safety

Events Timeline

YTD

Max

Events

FDA approval date

EMA approval date

Patent expiration date

Study first post date

Last update post date

Start date

Primary completion date

Completion date

Results first post date

Mock data
Subscribe for the real data

Commercial

No data

Clinical

Clinical Trials

1940 clinical trials

View more details

Mock data
Subscribe for the real data

Indications Phases 4

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Lymphoma	D008223	—	C85.9	107	355	95	15	40	547
Small cell lung carcinoma	D055752	—	—	58	179	69	4	27	304
Lung neoplasms	D008175	—	C34.90	67	165	63	4	23	286
Leukemia	D007938	—	C95	73	137	77	6	21	273
Non-hodgkin lymphoma	D008228	—	C85.9	59	143	34	5	9	213
Precursor cell lymphoblastic leukemia-lymphoma	D054198	—	C91.0	35	77	40	9	18	158
Large b-cell lymphoma diffuse	D016403	—	C83.3	47	92	21	1	8	146
Myeloid leukemia acute	D015470	—	C92.0	48	55	40	1	11	136
B-cell lymphoma	D016393	—	—	47	82	18	3	6	131
Hodgkin disease	D006689	—	C81	27	80	27	2	7	122

Show 25 more

Indications Phases 3

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Myeloid leukemia	D007951	—	C92	33	45	29	—	12	105
Neuroblastoma	D009447	EFO_0000621	—	20	35	21	—	5	77
Multiple myeloma	D009101	—	C90.0	12	45	10	—	6	69
Sarcoma	D012509	—	—	14	32	16	—	6	64
Recurrence	D012008	—	—	21	33	6	—	5	57
Myelodysplastic syndromes	D009190	—	D46	22	26	13	—	3	55
Plasma cell neoplasms	D054219	—	—	9	34	8	—	4	53
Central nervous system neoplasms	D016543	—	—	9	28	7	—	5	48
Carcinoma	D002277	—	C80.0	6	31	9	—	4	47
Ovarian neoplasms	D010051	EFO_0003893	C56	13	27	8	—	2	44

Show 118 more

Indications Phases 2

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
B-cell chronic lymphocytic leukemia	D015451	—	C91.1	8	17	—	—	6	28
Plasmacytoma	D010954	—	C90.3	5	14	—	—	2	21
Hematologic neoplasms	D019337	—	—	8	7	—	—	3	17
B-cell lymphoma marginal zone	D018442	—	C88.4	6	10	—	—	4	17
Graft vs host disease	D006086	—	D89.81	3	7	—	—	3	12
Adult t-cell leukemia-lymphoma	D015459	—	C91.5	3	6	—	—	2	10
Aids-related lymphoma	D016483	EFO_1001365	—	3	6	—	—	1	10
Neuroendocrine tumors	D018358	EFO_1001901	D3A.8	2	7	—	—	1	10
T-cell lymphoma cutaneous	D016410	—	C84.A	5	2	—	—	3	9
Mycosis fungoides	D009182	—	C84.0	5	3	—	—	2	9

Show 138 more

Indications Phases 1

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Large granular lymphocytic leukemia	D054066	—	—	2	—	—	—	2	4
Neuroepithelial neoplasms	D018302	—	—	2	—	—	—	—	2
Pharyngeal neoplasms	D010610	—	C14.0	2	—	—	—	—	2
Peritoneal neoplasms	D010534	—	—	2	—	—	—	—	2
Mesothelioma	D008654	—	C45	2	—	—	—	—	2
Myeloid leukemia accelerated phase	D015465	—	—	2	—	—	—	—	2
Melanoma	D008545	—	—	2	—	—	—	—	2
Thymus neoplasms	D013953	—	C37	1	—	—	—	1	2
Esophageal neoplasms	D004938	—	C15	1	—	—	—	—	1
Urethral neoplasms	D014523	EFO_0003846	—	1	—	—	—	—	1

Show 19 more

Indications Without Phase

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Chediak-higashi syndrome	D002609	Orphanet_167	D72.0	—	—	—	—	2	2
Paroxysmal hemoglobinuria	D006457	Orphanet_447	D59.12	—	—	—	—	1	1
Hemoglobinuria	D006456	—	R82.3	—	—	—	—	1	1
Multiple primary neoplasms	D009378	—	—	—	—	—	—	1	1
Ataxia	D001259	—	R27.0	—	—	—	—	1	1
Ataxia telangiectasia	D001260	Orphanet_100	G11.3	—	—	—	—	1	1
Telangiectasis	D013684	—	—	—	—	—	—	1	1
Cerebellar ataxia	D002524	—	—	—	—	—	—	1	1
Peripheral blood stem cell transplantation	D036102	—	—	—	—	—	—	1	1
Wiskott-aldrich syndrome	D014923	EFO_0003903	D82.0	—	—	—	—	1	1

Show 15 more

Epidemiology

Epidemiological information for investigational and approved indications

View more details

Drug

General

Drug common name	Etoposide phosphate
INN	—
Description	—
Classification	Unknown
Drug class	—
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)	—